Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 33Colorectal Neoplasms 13Neoplasms 11Pain, Postoperative 10Lung Neoplasms 9Brain Neoplasms 8Stomach Neoplasms 7Prostatic Neoplasms 7Pancreatic Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Melanoma 6Leukemia, Myeloid, Acute 5Ovarian Neoplasms 4Myoma 4Lymphoma, Non-Hodgkin 4Leiomyoma 4Hemorrhage 4Head and Neck Neoplasms 4Glioblastoma 4Colonic Neoplasms 4Agnosia 4Skin Neoplasms 3Recurrence 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neurotoxicity Syndromes 3Neoplasm Metastasis 3Nasopharyngeal Carcinoma 3Myelodysplastic Syndromes 3Multiple Endocrine Neoplasia Type 1 3

Interventions

Cisplatin 2sintilimab 1Sodium Chloride 1Resistance Training 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Nutrition Assessment 1Counseling 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Head and Neck Squamous Cell Carcinoma × Sodium Chloride × Clear all
NCT06240689 2024-02-05

A Prospective Randomized Controlled Study of Immune Checkpoint Maintenance Therapy After Radiotherapy and Chemotherapy for Locally Advanced Head and Neck Tumors Based on Peripheral Blood CD8Tex Detection in Peripheral Blood

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
104 enrolled
Head & Neck

Locally Advanced Head and Neck Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡